http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0311701-B8
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44367c7b17bf07d2d403f117a3fe1a97 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 |
filingDate | 2003-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1319b16858b8d28683a7bca4ff7aafab |
publicationDate | 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-PI0311701-B8 |
titleOfInvention | multiparticulate dosage pharmaceutical formulation coated with controlled release of lamotrigine |
abstract | "multiparticulate dosage formulation with controlled release of lamotrigine, pharmaceutical composition, process for the preparation of a pharmaceutical composition of lamotrigine, method for reducing peak fluctuation and deposition of drug concentration in a patient's blood plasma, method for improving a patient's compliance by reducing dosing frequency to once daily, method for safer administration of lamotrigine, method for providing a therapeutic blood plasma concentration of lamotrigine, and use of the formulation." The present invention relates to controlled release formulations of rapidly disintegrating multiple particles of lamotrigine having an improved pharmacokinetic profile and improved patient compliance and a process for preparing the formulations. the invention provides better control of blood plasma levels than conventional tablet formulations that are administered once a day. |
priorityDate | 2002-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3878 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507016 |
Total number of triples: 24.